홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Triethylamine → HCID 178455614, 화합물

HRID 1657256
인쇄

반응식

HRID 1657256 반응식
[NH2:1][CH:2]([CH2:13][CH:14]1[CH2:19][CH2:18][CH2:17][CH2:16][CH2:15]1)[CH:3]([OH:12])[CH:4]([C:6]1[CH2:11][CH2:10][CH2:9][CH2:8][CH:7]=1)[OH:5].[C:20]([S:24]([CH2:27][C@@H:28]([CH2:54][C:55]1[CH:60]=[CH:59][CH:58]=[CH:57][CH:56]=1)[C:29]([NH:31][C@H:32]([C:51](O)=[O:52])[CH2:33][C:34]1[N:38](C2C=CC([N+]([O-])=O)=CC=2[N+]([O-])=O)[CH:37]=[N:36][CH:35]=1)=[O:30])(=[O:26])=[O:25])([CH3:23])([CH3:22])[CH3:21].C(N(CC)CC)C.C1C=CC2N(O)N=NC=2C=1.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[N+](C1C=C([N+]([O-])=O)C=CC=1N1C=C(CCC(N)=O)N=C1)([O-])=O.C(O)(=S)C(C)O>C(#N)C.CN(C)C=O>[C:20]([S:24]([CH2:27][C@@H:28]([CH2:54][C:55]1[CH:56]=[CH:57][CH:58]=[CH:59][CH:60]=1)[C:29]([NH:31][C@@H:32]([CH2:33][C:34]1[N:38]=[CH:37][NH:36][CH:35]=1)[C:51]([NH:1][C@@H:2]([CH2:13][CH:14]1[CH2:19][CH2:18][CH2:17][CH2:16][CH2:15]1)[C@@H:3]([OH:12])[C@H:4]([C:6]1[CH2:11][CH2:10][CH2:9][CH2:8][CH:7]=1)[OH:5])=[O:52])=[O:30])(=[O:26])=[O:25])([CH3:23])([CH3:21])[CH3:22]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

10

반응물 7

HCID 8471TriethylamineHCID 757711-HydroxybenzotriazoleHCID 2733084Methanaminium, N-((1H-benzotriazol-1-yloxy)(dimethylamino)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 22845096N-[(S)-alpha-[(t-butylsulphonyl)methyl]hydrocinnamoyl]-3-(2,4-dinitrophenyl)-L-histidineHCID 545040113-Amino-4-cyclohexyl-1-(1-cyclohexen-1-yl)-1,2-butanediol
HCID 131717471
1-(2,4-Dinitrophenyl)imidazol-4-propionamide
HCID 178473673HCID 178473673, 화합물

생성물 1

HCID 178455614HCID 178455614, 화합물

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6342Acetonitrile용매

실험 절차

A mixture of 100 mg (0.37 mmol) of (1S or R,2R,3S)-3-amino-4-cyclohexyl-1-(1-cyclohexen-1-yl)-1,2-butanediol and 257 mg (0.41 mmol) of N-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamoyl]-3-(2,4-dinitrophenyl)-L-histidine in 15 ml of acetonitrile is treated under argon in succession at room temperature with 83 mg (0.82 mmol) of triethylamine, 67 mg (0.41 mmol) of HOBT and 168 mg (0.41 mmol) of HBTU and the reaction mixture is thereafter stirred at room temperature for 3 hours. For the working-up, the reaction mixture is concentrated under reduced pressure to about 1/4 of the original volume, then diluted with 50 ml of ethyl acetate and washed in succession with water, saturated sodium bicarbonate solution, water and saturated sodium chloride solution. The organic phase is dried over sodium sulphate and evaporated under reduced pressure, and the residue is chromatographed on silica gel with a 98:2 mixture of methylene chloride and methanol as the eluting agent, whereby there are obtained 140 mg (0.17 mmol) of (S)-α-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamido]-N-[(1S,2R,3S or R)-1-(cyclohexylmethyl)-3-(1-cyclohexen-1-yl)-2,3-dihydroxypropyl]-1-(2,4-dinitrophenyl)imidazole-4-propionamide in the form of a yellow foam, MS: 838 (M+H)+. This is dissolved in 3 ml of dimethylformamide and stirred at room temperature for 3 hours with 0.15 ml (1.7 mmol) of thiolactic acid. Thereafter, the reaction solution is evaporated in a high vacuum, the residue is dissolved in 15 ml of ethyl acetate and the reaction solution is washed in succession with saturated sodium carbonate solution, water and saturated sodium chloride solution. The yellowish coloured ethyl acetate phase is dried over sodium sulphate and evaporated under reduced pressure. For purification, the residue (120 mg) is chromatographed on silica gel with a 95:5 mixture of methylene chloride and methanol, which contains 0.1% ammonium hydroxide, as the eluting agent. After lyophilization from dioxan there are obtained 85 mg of (S)-α-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamamido]-N-[(1S,2R,3S)-3-(1-cyclohexen-1-yl)-1-(cyclohexylmethyl)-2,3-dihydroxypropyl]imidazole-4-propionamide as a yellowish powder, MS: 671 (M+H)+.

후처리

  1. concentrationthe reaction mixture is concentrated under reduced pressure to about 1/4 of the original volume
  2. additiondiluted with 50 ml of ethyl acetate
  3. washwashed in succession with water, saturated sodium bicarbonate solution, water and saturated sodium chloride solution
  4. dry with materialThe organic phase is dried over sodium sulphate
  5. customevaporated under reduced pressure
  6. customthe residue is chromatographed on silica gel with a 98:2 mixture of methylene chloride and methanol as the eluting agent, whereby there
  7. customare obtained 140 mg (0.17 mmol) of (S)-α-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamido]-
  8. customThereafter, the reaction solution is evaporated in a high vacuum
  9. dissolutionthe residue is dissolved in 15 ml of ethyl acetate
  10. washthe reaction solution is washed in succession with saturated sodium carbonate solution, water and saturated sodium chloride solution
  11. dry with materialThe yellowish coloured ethyl acetate phase is dried over sodium sulphate
  12. customevaporated under reduced pressure
  13. customFor purification
  14. customthe residue (120 mg) is chromatographed on silica gel with a 95:5 mixture of methylene chloride and methanol, which

출처 및 근거

ORD 기록
ord-ef36bb8e535745439280f42e5da518fb
출처 데이터셋
uspto-grants-1993_10
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05256645

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트